Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options
Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.
Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.
Illicit trade in medicines and cosmetics tops R6.6bn a year in South Africa, exposing consumers to counterfeit products, a new report warns.
A court has upheld restrictions on compounded semaglutide at iDexis while regulatory investigations continue.
WHO Africa director Mohamed Janabi urged governments to finance primary healthcare and pursue health sovereignty.
Unpaid specialist training is growing in South Africa as scarce funded posts leave doctors working without salaries.
Discovery earnings growth accelerated as stronger cash generation, Discovery Bank and Vitality Health lifted performance.